Related Experiment Video
Updated: May 11, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
BRCA1 is a negative modulator of the PRC2 complex
Lan Wang1, Xianzhuo Zeng, Shuai Chen
1Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Abstract:
The Polycomb-repressive complex 2 (PRC2) is important for maintenance of stem cell pluripotency and suppression of cell differentiation by promoting histone H3 lysine 27 trimethylation (H3K27me3) and transcriptional repression of differentiation genes. Here we show that the tumour-suppressor protein BRCA1 interacts with the Polycomb protein EZH2 in mouse embryonic stem (ES) and human breast cancer cells. The BRCA1-binding region in EZH2 overlaps with the noncoding RNA (ncRNA)-binding domain, and BRCA1 expression inhibits the binding of EZH2 to the HOTAIR ncRNA. Decreased expression of BRCA1 causes genome-wide EZH2 re-targeting and elevates H3K27me3 levels at PRC2 target loci in both mouse ES and human breast cancer cells. BRCA1 deficiency blocks ES cell differentiation and enhances breast cancer migration and invasion in an EZH2-dependent manner. These results reveal that BRCA1 is a key negative modulator of PRC2 and that loss of BRCA1 inhibits ES cell differentiation and enhances an aggressive breast cancer phenotype by affecting PRC2 function.
Insights
The tumor suppressor BRCA1 negatively regulates Polycomb Repressive Complex 2 (PRC2) by interacting with EZH2. Loss of BRCA1 impairs stem cell differentiation and promotes aggressive breast cancer via PRC2.
Area of Science:
- Epigenetics
- Molecular Biology
- Cancer Biology
Background:
- Polycomb-repressive complex 2 (PRC2) epigenetically regulates gene expression by catalyzing histone H3 lysine 27 trimethylation (H3K27me3).
- PRC2 is crucial for maintaining stem cell pluripotency and suppressing differentiation.
- Aberrant PRC2 activity is implicated in various cancers, including breast cancer.
Purpose of the Study:
- To investigate the interaction between tumor suppressor BRCA1 and PRC2 component EZH2.
- To elucidate the role of BRCA1 in modulating PRC2 function in embryonic stem cells and breast cancer.
Main Methods:
- Co-immunoprecipitation assays to detect BRCA1-EZH2 interaction.
- RNA immunoprecipitation followed by sequencing (RIP-seq) to assess EZH2 binding to HOTAIR ncRNA.
- Chromatin immunoprecipitation (ChIP) to quantify H3K27me3 levels.
- Cell differentiation assays in mouse embryonic stem cells.
- Cell migration and invasion assays in human breast cancer cells.
Main Results:
- BRCA1 directly interacts with EZH2, inhibiting its binding to HOTAIR ncRNA.
- BRCA1 deficiency leads to genome-wide EZH2 re-targeting and increased H3K27me3 levels at PRC2 target loci.
- Loss of BRCA1 impairs mouse embryonic stem cell differentiation and enhances human breast cancer cell migration and invasion.
- These effects are dependent on EZH2 activity.
Conclusions:
- BRCA1 acts as a critical negative regulator of PRC2 activity.
- Loss of BRCA1 function disrupts stem cell homeostasis and promotes an aggressive breast cancer phenotype through aberrant PRC2 modulation.
Related Concept Videos
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene
Ras is a superfamily...
Positive Regulator Molecules
Abnormal Proliferation

